These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37735664)

  • 1. Feasibility of delivering supervised exercise training following surgical resection and during adjuvant chemotherapy for pancreatic ductal adenocarcinoma (PRECISE): a case series.
    Brown M; O'Connor D; Turkington R; Eatock M; Vince R; Hulme C; Bowdery R; Robinson R; Wadsley J; Maraveyas A; Prue G
    BMC Sports Sci Med Rehabil; 2023 Sep; 15(1):116. PubMed ID: 37735664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of home-based exercise training during adjuvant treatment for metastatic castrate-resistant prostate cancer patients treated with an androgen receptor pathway inhibitor (EXACT).
    Brown M; Murphy MH; McAneney H; McBride K; Crawford F; Cole A; O'Sullivan JM; Jain S; Prue G
    Support Care Cancer; 2023 Jul; 31(7):442. PubMed ID: 37402060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trial.
    Bouchart C; Navez J; Borbath I; Geboes K; Vandamme T; Closset J; Moretti L; Demetter P; Paesmans M; Van Laethem JL
    BMC Cancer; 2023 Sep; 23(1):891. PubMed ID: 37735634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.
    Labori KJ; Bratlie SO; Andersson B; Angelsen JH; Biörserud C; Björnsson B; Bringeland EA; Elander N; Garresori H; Grønbech JE; Haux J; Hemmingsson O; Liljefors MG; Myklebust TÅ; Nymo LS; Peltola K; Pfeiffer P; Sallinen V; Sandström P; Sparrelid E; Stenvold H; Søreide K; Tingstedt B; Verbeke C; Öhlund D; Klint L; Dueland S; Lassen K;
    Lancet Gastroenterol Hepatol; 2024 Mar; 9(3):205-217. PubMed ID: 38237621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supervised Home-Based Exercise Prehabilitation in Unfit Patients Scheduled for Pancreatic Surgery: Protocol for a Multicenter Feasibility Study.
    Hildebrand ND; Wijma AG; Bongers BC; Rensen SS; den Dulk M; Klaase JM; Olde Damink SWM
    JMIR Res Protoc; 2023 Sep; 12():e46526. PubMed ID: 37676715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A feasibility study to investigate the utility of a home-based exercise intervention during and after neo-adjuvant chemotherapy for oesophago-gastric cancer-the ChemoFit study protocol.
    Chmelo J; Phillips AW; Greystoke A; Charman SJ; Avery L; Hallsworth K; Welford J; Sinclair RCF
    Pilot Feasibility Stud; 2020; 6():50. PubMed ID: 32346484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.
    Ghaneh P; Palmer D; Cicconi S; Jackson R; Halloran CM; Rawcliffe C; Sripadam R; Mukherjee S; Soonawalla Z; Wadsley J; Al-Mukhtar A; Dickson E; Graham J; Jiao L; Wasan HS; Tait IS; Prachalias A; Ross P; Valle JW; O'Reilly DA; Al-Sarireh B; Gwynne S; Ahmed I; Connolly K; Yim KL; Cunningham D; Armstrong T; Archer C; Roberts K; Ma YT; Springfeld C; Tjaden C; Hackert T; Büchler MW; Neoptolemos JP;
    Lancet Gastroenterol Hepatol; 2023 Feb; 8(2):157-168. PubMed ID: 36521500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trial.
    Labori KJ; Lassen K; Hoem D; Grønbech JE; Søreide JA; Mortensen K; Smaaland R; Sorbye H; Verbeke C; Dueland S
    BMC Surg; 2017 Aug; 17(1):94. PubMed ID: 28841916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Resistance Exercise on Muscle Mass in Glioblastoma in Survivors (RESIST): Protocol for a Randomized Controlled Trial.
    Keats MR; Grandy SA; Blanchard C; Fowles JR; Neyedli HF; Weeks AC; MacNeil MV
    JMIR Res Protoc; 2022 May; 11(5):e37709. PubMed ID: 35507403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine and nanoparticle albumin-bound paclitaxel combination therapy as neoadjuvant chemotherapy for resectable/borderline resectable pancreatic ductal adenocarcinoma (PDAC-GS/GA-rP2, CSGO-HBP-015).
    Yamada D; Kobayashi S; Takahashi H; Akita H; Yamada T; Asaoka T; Shimizu J; Takeda Y; Yokoyama S; Tsujie M; Tomokuni A; Tanemura M; Morimoto O; Murakami M; Kim Y; Nakahira S; Hama N; Sugimoto K; Hashimoto K; Doki Y; Eguchi H
    Trials; 2021 Aug; 22(1):568. PubMed ID: 34446057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study.
    Motoi F; Satoi S; Honda G; Wada K; Shinchi H; Matsumoto I; Sho M; Tsuchida A; Unno M;
    J Gastroenterol; 2019 Feb; 54(2):194-203. PubMed ID: 30182219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A feasibility trial of prehabilitation before oesophagogastric cancer surgery using a multi-component home-based exercise programme: the ChemoFit study.
    Chmelo J; Phillips AW; Greystoke A; Charman SJ; Avery L; Hallsworth K; Welford J; Cooper M; Sinclair RCF
    Pilot Feasibility Stud; 2022 Aug; 8(1):173. PubMed ID: 35945625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neo-train: study protocol and feasibility results for a two-arm randomized controlled trial investigating the effect of supervised exercise during neoadjuvant chemotherapy on tumour response in patients with breast cancer.
    Kjeldsted E; Ammitzbøll G; Jørgensen LB; Lodin A; Bojesen RD; Ceballos SG; Rosthøj S; Lænkholm AV; Skou ST; Jack S; Gehl J; Dalton SO
    BMC Cancer; 2023 Aug; 23(1):777. PubMed ID: 37598196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Oncologist-Referred Exercise and Healthy Eating Programming as a Part of Supportive Adjuvant Care for Early Breast Cancer.
    Kirkham AA; Van Patten CL; Gelmon KA; McKenzie DC; Bonsignore A; Bland KA; Campbell KL
    Oncologist; 2018 Jan; 23(1):105-115. PubMed ID: 28982801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2-3 trial.
    Reni M; Balzano G; Zanon S; Zerbi A; Rimassa L; Castoldi R; Pinelli D; Mosconi S; Doglioni C; Chiaravalli M; Pircher C; Arcidiacono PG; Torri V; Maggiora P; Ceraulo D; Falconi M; Gianni L
    Lancet Gastroenterol Hepatol; 2018 Jun; 3(6):413-423. PubMed ID: 29625841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Aerobic Exercise on Cardiorespiratory Fitness, Cardiovascular Risk Factors, and Patient-Reported Outcomes in Long-Term Breast Cancer Survivors: Protocol for a Randomized Controlled Trial.
    Nilsen TS; Sæter M; Sarvari SI; Reinertsen KV; Johansen SH; Edvardsen ER; Hallén J; Edvardsen E; Grydeland M; Kiserud CE; Lie HC; Solberg PA; Wisløff T; Sharples AP; Raastad T; Haugaa KH; Thorsen L
    JMIR Res Protoc; 2023 Mar; 12():e45244. PubMed ID: 36920460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal prehabilitation to enhance functional capacity of patients with esophageal cancer during concurrent neoadjuvant chemotherapies-a randomized feasibility trial.
    St-Pierre J; Coca-Martinez M; Drummond K; Minnella E; Ramanakumar AV; Ferri L; Carli F; Scheede-Bergdahl C
    Dis Esophagus; 2024 Nov; 37(12):. PubMed ID: 39377252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of high-intensity exercise training on physical fitness, quality of life and treatment outcomes after oesophagectomy for cancer of the gastro-oesophageal junction: PRESET pilot study.
    Simonsen C; Thorsen-Streit S; Sundberg A; Djurhuus SS; Mortensen CE; Qvortrup C; Pedersen BK; Svendsen LB; de Heer P; Christensen JF
    BJS Open; 2020 Oct; 4(5):855-864. PubMed ID: 32856785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a randomized controlled trial.
    Morielli AR; Usmani N; Boulé NG; Severin D; Tankel K; Nijjar T; Joseph K; Fairchild A; Courneya KS
    Trials; 2018 Jan; 19(1):35. PubMed ID: 29329555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of supervised aerobic exercise on cardiorespiratory fitness and patient-reported health outcomes in colorectal cancer patients undergoing adjuvant chemotherapy-a pilot study.
    Zopf EM; Schulz H; Poeschko J; Aschenbroich K; Wilhelm T; Eypasch E; Kleimann E; Severin K; Benz J; Liu E; Bloch W; Baumann FT
    Support Care Cancer; 2022 Mar; 30(3):1945-1955. PubMed ID: 34623488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.